Drug pricing reform will hurt domestic sector

A report released by IMS Health Korea said Korea's pharmaceutical sector could lose up to 2.28 trillion won if the government’s measures to cut medicine prices are adopted as planned starting next year.

“We have revised our forecast as the new system will take effect in January next year. When it is implemented, the combined sales for 20 leading Korean drug firms will drop by 1.54 trillion w...